Tower Research Capital (TRC)’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.1K | Sell |
2,984
-3,344
| -53% | -$11.3K | ﹤0.01% | 3963 |
|
|
2025
Q1 | $9.62K | Buy |
6,328
+3,928
| +164% | +$5.97K | ﹤0.01% | 3751 |
|
|
2024
Q4 | $5.28K | Buy |
2,400
+432
| +22% | +$950 | ﹤0.01% | 4320 |
|
|
2024
Q3 | $4.9K | Sell |
1,968
-10,099
| -84% | -$25.1K | ﹤0.01% | 4382 |
|
|
2024
Q2 | $15.4K | Buy |
12,067
+7,174
| +147% | +$9.18K | ﹤0.01% | 3905 |
|
|
2024
Q1 | $14.1K | Buy |
4,893
+2,708
| +124% | +$7.83K | ﹤0.01% | 3334 |
|
|
2023
Q4 | $16.1K | Sell |
2,185
-1,063
| -33% | -$7.81K | ﹤0.01% | 3797 |
|
|
2023
Q3 | $24.9K | Buy |
3,248
+2,428
| +296% | +$18.6K | ﹤0.01% | 3174 |
|
|
2023
Q2 | $8.32K | Sell |
820
-1,948
| -70% | -$19.8K | ﹤0.01% | 4423 |
|
|
2023
Q1 | $27K | Sell |
2,768
-3,608
| -57% | -$35.2K | ﹤0.01% | 3109 |
|
|
2022
Q4 | $31K | Buy |
6,376
+3,659
| +135% | +$17.8K | ﹤0.01% | 2716 |
|
|
2022
Q3 | $39K | Sell |
2,717
-111
| -4% | -$1.59K | ﹤0.01% | 3377 |
|
|
2022
Q2 | $15K | Buy |
2,828
+1,312
| +87% | +$6.96K | ﹤0.01% | 4071 |
|
|
2022
Q1 | $10K | Buy |
1,516
+206
| +16% | +$1.36K | ﹤0.01% | 4312 |
|
|
2021
Q4 | $21K | Buy |
1,310
+1,077
| +462% | +$17.3K | ﹤0.01% | 3605 |
|
|
2021
Q3 | $6K | Buy |
+233
| New | +$6K | ﹤0.01% | 4753 |
|